Oncologic Outcome and Quality of Life of patients with node negative vulvar cancer after sentinel node biopsy or systematic inguino-femoral lymphadenectomy - an epidemiological investigation

Oncologic Outcome and Quality of Life of patients with node negative vulvar cancer after sentinel node biopsy or systematic inguino-femoral lymphadenectomy - an epidemiological investigation - VulvaN0

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00013298

Enrollment

120

Registered

2019-01-25

Start date

2019-07-08

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C51

Interventions

Group 1: Vulvar cancer Stage T1/2 with sentinel node biopsy Survey of Outcome and QoL (Quality of Life) Group 2: Vulvar cancer Stage T1/2 with inguino-femoral lymph node metastasis Survey of Outcome a

Eligibility

Sex/Gender

Female

Age

20 Years to 99 Years

Inclusion criteria

Inclusion criteria: Node negative Vulvar cancer

Exclusion criteria

Exclusion criteria: Lymphnode metastasis Advanced vulvar cancer FIGO Stage III/IV

Design outcomes

Primary

Measure	Time frame
Disease free survival; Local recurrence or distant metastasis found by MRI, CT or ultrasound scan found in regular Tumor follow up.	—

Secondary

Measure	Time frame
Quality of Life by SF 12(R) questionaire one-time of follow up	—

Countries

Germany

Contacts

Public ContactDirk M. Forner

Evangelisches Krankenhaus Kalk

forner@evkk.de0221-8289-5485

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026